Publicaciones en colaboración con investigadores/as de Universitat de València (11)

2018

  1. JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study

    Thorax, Vol. 73, Núm. 6, pp. 519-529

  2. MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology

    Respiratory Research, Vol. 19, Núm. 1

  3. Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/ perfusion matching

    PLoS ONE, Vol. 13, Núm. 1

2016

  1. Activation of PPARβ/δ prevents hyperglycaemia-induced impairment of Kv7 channels and cAMP-mediated relaxation in rat coronary arteries

    Clinical Science, Vol. 130, Núm. 20, pp. 1823-1836

2015

  1. Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity

    Journal of Hypertension, Vol. 33, Núm. 9, pp. 1831-1844

2014

  1. Ceramide mediates acute oxygen aensing in vascular tissues

    Antioxidants and Redox Signaling, Vol. 20, Núm. 1, pp. 1-14

  2. PPARβ activation restores the high glucose-induced impairment of insulin signalling in endothelial cells

    British Journal of Pharmacology, Vol. 171, Núm. 12, pp. 3089-3102

2013

  1. Role of tetrahydrobiopterin in pulmonary vascular remodelling associated with pulmonary fibrosis

    Thorax, Vol. 68, Núm. 10, pp. 938-948

2011

  1. Ceramide inhibits Kv currents and contributes to TP-receptor-induced vasoconstriction in rat and human pulmonary arteries

    American Journal of Physiology - Cell Physiology, Vol. 301, Núm. 1

2008

  1. The HERACLES cardiovascular network

    Revista Espanola de Cardiologia, Vol. 61, Núm. 1, pp. 66-75

2003

  1. Cytosolic Ca2+ and phosphoinositide hydrolysis linked to constitutively active α1D-adrenoceptors in vascular smooth muscle

    Journal of Pharmacology and Experimental Therapeutics, Vol. 305, Núm. 3, pp. 1006-1014